Document:

EXHIBIT 10.1

                     Amendment No. 1 to Employment Agreement

      This Amendment No. 1 dated as of July 5, 2005, by and between MediaBay,
Inc. (the "Company") and Jeffrey Dittus (the "Executive") amends the Employment
Agreement made on June 6, 2005 by and between the Company and the Executive (the
"Agreement"). Capitalized items used herein and not defined herein shall have
the same meanings as set forth in the Agreement.

                               W I T N E S S E T H

(1)   The following shall be added as a new Section 9(f) to the Agreement:

      "(f)  In the event the Executive is terminated by the Company, other than
            for Cause (as defined in the Agreement or as defined in the stock
            incentive plan under which the Existing Option (as defined below)
            was granted) or the Executive terminates his employment with the
            Company for Good Reason (as defined in the Agreement),
            notwithstanding anything to the contrary in any option agreement
            granted to the Executive prior to the date hereof under the
            Company's stock incentive plans (the "Existing Options"), each
            Existing Option shall be immediately vested in full and shall remain
            exercisable for the full term as provided for in the respective
            Existing Option, regardless of any provision in any agreement
            relating to such Existing Option providing for earlier expiration of
            the Existing Option as a result of termination of the Executive's
            employment."

(2)   Each agreement relating to an Existing Option is hereby amended to (i)
      provide that the Existing Option shall fully vest immediately upon
      termination of the Executive's employment with the Company, other than for
      Cause (as defined in the Agreement or under the stock incentive plan under
      which such Existing Option was granted) and (ii) delete any provision
      provided for termination of the Existing Option as a result of termination
      of the Executive's employment with the Company, other than for Cause (as
      defined in the Agreement or under the stock incentive plan under which
      such Existing Option was granted.

(3)   All other terms and provisions of the Agreement and agents relating to the
      Existing Option remain unchanged and of full force and effect.

      IN WITNESS WHEREOF, the parties have executed this Agreement as of the
date first written above.

                                         "COMPANY"

                                         MEDIABAY, INC., a Florida Corporation

                                         By: /s/ Joseph Rosetti
                                             ----------------------------------
                                              Printed Name:  Joseph Rosetti
                                              Title:  Chairman

                                         "EXECUTIVE"

                                         /s/ Jeffrey Dittus
                                         ------------------
                                         Jeffrey A. DittusEXHIBIT
      10.1
       

      

      PURCHASE
        AND SALE AGREEMENT

      by
        and among

      

      CLINICAL
        RESULTS, INC.,

      

      EACH
        OF DAVID POLLOCK AND RICHARD DOUGLAS REITZ,

      as
        Sellers

      

      

      and

      

      

      HYDRON
        TECHNOLOGIES, INC.,

      as
        Buyer

      

      

      

      

      Dated
        as of July 1, 2005

      

      

      

       

       

       

       

       

       

      

      

      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

          
          

        

      

      TABLE
        OF CONTENTS

      

      Page

      
        
          
            
              
                	 	 	 
	
                        1.

                      	
                        SALE
                          AND PURCHASE

                      	
                        3

                      
	
                        2.

                      	
                        PURCHASE
                          PRICE

                      	
                        3

                      
	
                        3.

                      	
                        CLOSING;
                          CLOSING DELIVERIES

                      	
                        4

                      
	 	
                        3.1.  Closing

                      	
                        4

                      
	
                        4.

                      	
                        REPRESENTATIONS
                          AND WARRANTIES OF BUYER

                      	
                        4

                      
	 	
                        4.1.  Existence;
                          Good Standing

                      	
                        4

                      
	 	
                        4.2.  Authorization,
                          Validity and Effect of Agreements

                      	
                        4

                      
	 	
                        4.3.  No
                          Violation

                      	
                        4

                      
	 	
                        4.4.  Capital
                          Stock

                      	
                        5

                      
	 	
                        4.5.  Issuance
                          of Hydron Shares

                      	
                        5

                      
	 	
                        4.6.  No
                          Brokers

                      	
                        5

                      
	
                        5.

                      	
                        REPRESENTATIONS
                          AND WARRANTIES OF THE COMPANY AND EACH SELLERS

                      	
                        5

                      
	 	
                        5.1.  Existence;
                          Good Standing

                      	
                        5

                      
	 	
                        5.2.  Authorization,
                          Validity and Effect of Agreements

                      	
                        5

                      
	 	
                        5.3.  No
                          Violation

                      	
                        6

                      
	 	
                        5.4.  No
                          Brokers

                      	
                        6

                      
	 	
                        5.5.  Ownership
                          of Securities

                      	
                        6

                      
	 	
                        5.6.  Subsidiaries

                      	
                        6

                      
	 	
                        5.7.  Capitalization

                      	
                        6

                      
	 	
                        5.8.  Corporate
                          Records; Books

                      	
                        7

                      
	 	
                        5.9.  Financial
                          Statements

                      	
                        7

                      
	 	
                        5.10.  Undisclosed
                          Liabilities; Material Defaults

                      	
                        7

                      
	 	
                        5.11.  Absence
                          of Certain Changes

                      	
                        7

                      
	 	
                        5.12.  Title.

                      	
                        8

                      
	 	
                        5.13.  Litigation

                      	
                        8

                      
	 	
                        5.14.  Taxes

                      	
                        8

                      
	 	
                        5.15.  Compliance
                          with Law and Applicable Governmental and Other Regulations

                      	
                        8

                      
	 	
                        5.16.  Intellectual
                          Property

                      	
                        8

                      
	 	
                        5.17.  Contracts

                      	
                        9

                      
	 	
                        5.18.  Dealings
                          with Affiliates

                      	
                        9

                      
	 	
                        5.19.  Investment
                          Representations

                      	
                        9

                      
	
                        6.

                      	
                        COVENANTS

                      	
                        10

                      
	 	
                        6.1.  No
                          Disposition; No Liens

                      	
                        10

                      
	 	
                        6.2  Regular
                          Course of Business

                      	
                        10

                      
	 	
                        6.3.  Payments;
                          No Solicitation

                      	
                        11

                      
	 	
                        6.4.  Certain
                          Commitments

                      	
                        11

                      
	 	
                        6.5.  Filings;
                          Consents; Other Actions

                      	
                        11

                      
	 	
                        6.6.  Publicity

                      	
                        12

                      
	
                        7.

                      	
                        CONDITIONS

                      	
                        12

                      
	 	
                        7.1.  Conditions
                          to Obligation of Sellers to Sell the Securities

                      	
                        12

                      
	 	
                        7.2.  Conditions
                          to Obligation of Buyer to Purchase the Securities

                      	
                        13

                      

              

               

               

              
                
                  
                  

                

                
                  -i-

                  
                    

                  

                

                
                  
                  

                

              

               

              
                	 	 	 
	
                        8.

                      	
                        INDEMNIFICATION

                      	
                        14

                      
	 	
                        8.1.  Survival
                          of Representations and Warranties

                      	
                        14

                      
	 	
                        8.2.  Indemnification
                          by the Sellers.

                      	
                        14

                      
	 	
                        8.3.  Indemnification
                          by Buyer.

                      	
                        15

                      
	 	
                        8.4.  Third-Party
                          Claims

                      	
                        15

                      
	
                        9.

                      	
                        NONCOMPETE

                      	
                        16

                      
	 	
                        9.1  Non-Competition
                          Covenant

                      	
                        16

                      
	 	
                        9.2  Non-disclosure;
                          Confidentiality

                      	
                        18

                      
	
                        10.

                      	
                        TERMINATION

                      	
                        20

                      
	 	
                        10.1  Methods
                          of Termination

                      	
                        20

                      
	 	
                        10.2  Procedure
                          Upon Termination

                      	
                        20

                      
	
                        11.

                      	
                        GENERAL
                          PROVISIONS

                      	
                        21

                      
	 	
                        11.1.  Notices

                      	
                        21

                      
	 	
                        11.2.  Assignment;
                          Binding Effect

                      	
                        22

                      
	 	
                        11.3.  Entire
                          Agreement

                      	
                        22

                      
	 	
                        11.4.  Amendment

                      	
                        22

                      
	 	
                        11.5.  GOVERNING
                          LAW

                      	
                        22

                      
	 	
                        11.6.  Counterparts

                      	
                        22

                      
	 	
                        11.7.  Headings

                      	
                        22

                      
	 	
                        11.8.  Interpretation

                      	
                        22

                      
	 	
                        11.9.  Waivers

                      	
                        22

                      
	 	
                        11.10.  Severability

                      	
                        23

                      
	 	
                        11.12.  Enforcement
                          of Agreement

                      	
                        23

                      
	 	
                        11.13.  Costs

                      	
                        23

                      
	 	
                        11.14.  Schedules

                      	
                        23

                      
	 	
                        11.15.
                            No Third Party Beneficiaries

                      	
                        23

                      
	 	
                        11.16.  Due
                          Diligence

                      	
                        23

                      
	 	
                        11.17.  Lock-up
                          Agreements

                      	
                        23

                      
	 	
                        11.18  Board
                          of Directors

                      	
                        23

                      
	 	 	 

              

            

          

        

        EXHIBITS

         

        Exhibit
          A
          - Restrictive Legend   

        
 

      

      
        
          
          

        

        
          -ii-

          
            

          

        

        
          
          

          
          

        

      

      PURCHASE
        AND SALE AGREEMENT

      

      THIS
        AGREEMENT dated as of July 1, 2005 (this “Agreement”),
        is
        entered into by and among CLINICAL RESULTS, INC., a Delaware corporation
        (the
“Company”),
        each
        of DAVID POLLOCK, an individual (“Pollock”),
        and
        RICHARD DOUGLAS REITZ, an individual (“Reitz”)
        (each
        of Pollock and Reitz, a "Seller"
        and
        collectively, the "Sellers")
        and
        HYDRON TECHNOLOGIES, INC., a New York corporation (the “Buyer”).

      

      W
        I T N E S S E T H:

      

      WHEREAS,
        each of
        the Sellers is the owner of shares (“Shares”)
        of
        common stock, par value $.01 per share (the "Common
        Stock"),
        of
        the Company, aggregating the total issued and outstanding shares of Common
        Stock; and

      

      WHEREAS,
        Buyer
        desires to purchase from Sellers, and each of the Sellers desires to sell
        to
        Buyer, the Shares, upon the terms and subject to the conditions set forth
        in
        this Agreement.

      

      NOW,
        THEREFORE,
        in
        consideration of the mutual benefit to be derived from this Agreement and
        of the
        representations, warranties, conditions, covenants and agreements hereinafter
        contained, and other good and valuable consideration, the receipt and
        sufficiency of which is hereby acknowledged, Buyer, the Company and each
        of the
        Sellers hereby agree as follows:

      

      1.    SALE
        AND PURCHASE; INVESTMENT IN COMPANY

      

      (a) Each
        Seller hereby agrees to sell, transfer, assign and deliver to Buyer, and
        Buyer
        hereby agrees to purchase from each such Seller, the Shares owned by each
        such
        Seller for the Purchase Price (as defined in Section
        2 below).

      

      (b) At
        the
        Closing (as defined in Section
        3.1
        below),
        each Seller will deliver (or cause to be delivered) to Buyer, free and clear
        of
        all liens, restrictions, claims, charges and encumbrances of any nature
        (individually, a “Lien”
        and
        collectively, “Liens”),
        certificates (“Certificates”)
        representing the Shares of Common Stock owned by such Seller, together with
        such
        other documents as may be necessary for transfer of the Common Stock upon
        the
        transfer books and records of the Company into the name of Buyer, in form
        for
        good delivery. Such Certificates shall be in negotiable form accompanied
        by
        stock powers executed in blank. 

      

      2.    PURCHASE
        PRICE. The
        consideration to be paid by Buyer to each Seller for the Shares being sold
        by
        such Seller (the “Purchase
        Price”)
        shall
        be an aggregate of Two Million (2,000,000) shares of common stock, $.01 par
        value per share, of the Buyer (the “Hydron
        Common Stock”),
        evidenced by two stock certificates each evidencing ownership of One Million
        (1,000,000) shares of Common Stock registered in the names of Pollack and
        Reitz,
        respectively, and bearing a restrictive stock legend in the form attached
        as
Exhibit
        A
        hereto
        (collectively, the “Hydron
        Shares”).

      

      
        
          
          

        

        
          -3-

          
            

          

        

        
          
          

        

      

      3.    CLOSING.
        The
        closing of the transactions contemplated hereby (the “Closing”)
        shall
        take place on the date that all conditions set forth in Sections
        7.1 and 7.2
        have
        been satisfied or waived, but in no event later than July 31, 2005 (the
“Closing
        Time”),
        at
        the offices of Ruden McClosky Smith Schuster & Russell, P.A., 200 East
        Broward Boulevard, Fort Lauderdale, Florida 33301, or at such other time
        and
        location as the parties may agree.

      

      4.    REPRESENTATIONS
        AND WARRANTIES OF BUYER

      

      Buyer
        hereby represents and warrants to the Company and to each Seller as
        follows:

      

      4.1.    Existence;
        Good Standing.
        Buyer
        is a corporation duly incorporated, validly existing and in good standing
        under
        the laws of its jurisdiction of incorporation. The Buyer is duly qualified
        or
        licensed to do business in good standing in every jurisdiction in which the
        conduct of its business requires it to be so qualified or licensed.

      

      4.2.    Authorization,
        Validity and Effect of Agreements
        Buyer
        has the requisite corporate power and authority to execute and deliver this
        Agreement and all agreements and documents contemplated hereby to which Buyer
        is
        a party. The consummation by Buyer of the transactions contemplated hereby
        has
        been duly authorized by all requisite corporate action. This Agreement
        constitutes, and all agreements and documents contemplated hereby (when executed
        and delivered pursuant hereto for value received) will constitute, the valid
        and
        legally binding obligations of Buyer, enforceable against Buyer in accordance
        with their respective terms, subject to applicable bankruptcy, insolvency,
        moratorium or other similar laws relating to creditors' rights and general
        principles of equity.

      

      4.3.    No
        Violation.
        Neither
        the execution and delivery by Buyer of this Agreement, nor the consummation
        by
        Buyer of the transactions contemplated hereby in accordance with the terms
        hereof, will: (a) conflict with or result in a breach of any provisions
        of
        the Certificate of Incorporation or by-laws of Buyer; (b) violate, or conflict
        with, or result in a breach of any provision of, or constitute a default
        (or an
        event which, with notice or lapse of time or both, would constitute a default)
        under, or result in the termination or cancellation of, or give rise to a
        right
        of termination or cancellation of, or accelerate the performance required
        by, or
        result in the creation of any lien, security interest, charge or encumbrance
        upon any of the material properties of Buyer or its subsidiaries under, or
        result in being declared void, voidable, or without further binding effect,
        any
        of the terms, conditions or provisions of any note, bond, mortgage, indenture,
        deed of trust or any material license, certificate of authority, franchise,
        permit, lease, contract, agreement or other instrument, commitment or obligation
        to which Buyer is a party, or by which Buyer or any of its properties is
        bound
        or affected, except for any of the foregoing matters which would not have
        a
        material adverse effect on the ability of Buyer to perform its obligations
        hereunder (a "Buyer
        Material Adverse Effect");
        or
        (c) other than such regulatory approvals and filings as may be required under
        applicable securities laws, require any material consent, approval or
        authorization of, or declaration, filing or registration with, any domestic
        governmental or regulatory authority, the failure to obtain or make which
        would
        have a Buyer Material Adverse Effect.

      

      
        
          
          

        

        
          -4-

          
            

          

        

        
          
          

        

      

      4.4.    Capital
        Stock.
        The
        authorized capital stock of Buyer consists of 30,000,000 shares of Common
        Stock
        and 5,000,000 shares of preferred stock, $.01 par value per share (
“Preferred
        Stock”),
        of
        which as of June 30, 2005, 9,310,336 shares of Common Stock, and no shares
        of
        Preferred Stock are issued and outstanding.

      

      4.5.    Issuance
        of Hydron Shares.
        The
        Hydron Shares that are required to be issued by the Company to the Sellers
        pursuant to, in accordance with the terms, and subject to the conditions
        set
        forth in this Agreement, shall, upon issuance and delivery, be duly authorized,
        validly issued, fully paid and non-assessable.

      

      4.6.    No
        Brokers.
        Buyer
        has not entered into any contract, arrangement or understanding with any
        person
        or firm which may result in the obligation of any party hereto to pay any
        finder's fees, brokerage or agent's commissions or other like payments in
        connection with the negotiations leading to this Agreement or the consummation
        of the transactions contemplated hereby. Buyer is not aware of any claim
        for
        payment of any finder's fees, brokerage or agent's commissions or other like
        payments in connection with the negotiations leading to this Agreement or
        the
        consummation of the transactions contemplated hereby.

      

      5.    REPRESENTATIONS
        AND WARRANTIES OF THE COMPANY AND EACH SELLER 

      

      The
        Company and each Seller hereby jointly and severally represents and warrants
        to
        Buyer as follows:

      

      5.1.    Existence;
        Good Standing.
        The
        Company is a corporation duly organized, validly existing and in good standing
        under the laws of its jurisdiction of incorporation. The Company is duly
        qualified or licensed to do business in good standing in every jurisdiction
        in
        which the conduct of its business requires it to be so qualified or
        licensed.

      

      5.2.    Authorization,
        Validity and Effect of Agreements.
        The
        Company has the requisite power and authority to execute and deliver this
        Agreement and all agreements and documents contemplated hereby. The consummation
        by the Company of the transactions contemplated hereby has been duly authorized
        by all requisite action. This Agreement constitutes, and all agreements and
        documents contemplated hereby to which the Company or a Seller is a party
        (when
        executed and delivered pursuant hereto for value received) will constitute,
        the
        valid and legally binding obligations of the Company and each such Seller,
        enforceable against the Company and each Seller in accordance with their
        respective terms, subject to applicable bankruptcy, insolvency, moratorium
        or
        other similar laws relating to creditors' rights and general principles of
        equity.

      

      
        
          
          

        

        
          -5-

          
            

          

        

        
          
          

        

      

      5.3.    No
        Violation.
        Neither
        the execution and delivery by the Company and each Seller of this Agreement,
        nor
        the consummation by the Company and each Seller of the transactions contemplated
        hereby in accordance with the terms hereof, will: (a) conflict with
        or
        result in a breach of any provisions of the articles of incorporation or
        bylaws
        of the Company, (b) violate, or conflict with, or result in a breach of any
        provision of, or constitute a default (or an event which, with notice or
        lapse
        of time or both, would constitute a default) under any of the terms, conditions
        or provisions of any material license, certificate of authority, franchise,
        permit, lease, contract, agreement or other instrument, commitment or obligation
        to which the Company or any Seller is a party, or by which the Company or
        any
        Seller or any of their respective properties is bound or affected, except
        for
        any of the foregoing matters which would not have a material adverse effect
        on
        the ability of the Company or such Seller to perform its respective obligations
        hereunder (a "Seller
        Material Adverse Effect");
        or
        (c) other than such regulatory approvals and filings as may be required under
        applicable Common Stock laws, require any material consent, approval or
        authorization of, or declaration, filing or registration with, any governmental
        or regulatory authority, the failure to obtain or make which would have a
        Seller
        Material Adverse Effect.

      

      5.4.    No
        Brokers.
        Neither
        the Company nor any Seller has entered into any contract, arrangement or
        understanding with any person or firm which may result in the obligation
        of any
        party hereto to pay any finder's fees, brokerage or agent's commissions or
        other
        like payments in connection with the negotiations leading to this Agreement,
        or
        the consummation of the transactions contemplated hereby. Neither the Company
        nor any Seller is aware of any claim for payment of any finder's fees, brokerage
        or agent's commissions or other like payments in connection with the
        negotiations leading to this Agreement or the consummation of the transactions
        contemplated hereby.

      

      5.5.    Ownership
        of Common Stock.
        Each
        Seller has good and valid title to the Shares of Common Stock owned by him,
        free
        and clear of all Liens of any nature whatsoever. Each Seller has full power
        and
        authority to sell, assign and transfer the Common Stock owned by him. Buyer
        will
        acquire good and valid title to all of the Common Stock, free and clear of
        all
        Liens of any nature whatsoever. The Company and each Seller, upon request,
        will
        execute (or cause to be executed) any additional documents necessary or
        reasonably desirable to complete the transfer of the Shares of Common Stock
        to
        Buyer.

      

      5.6.    Subsidiaries.
        The
        Company has no direct or indirect subsidiaries and the Company owns of record
        and beneficially all of the assets necessary or useful to operate the business
        of the Company.

      

      5.7.    Capitalization.
        The
        authorized capital stock of the Company consists of 1,000,000 shares of common
        stock, $0.0001 par value, per share. As of June 30, 2005, there were 1,000
        shares of Common Stock issued and outstanding. There are no outstanding (i)
        rights, including without limitation, any stock purchase warrants, options
        to
        purchase stock, securities convertible into shares of capital stock, or other
        rights which obligate the Company, or any Seller to issue, transfer or sell
        any
        shares of capital stock of the Company, or (ii) obligations of the Company
        or
        the Sellers to purchase, redeem or otherwise acquire any shares of capital
        stock
        or voting Common Stock convertible or exercisable into or exchangeable for
        capital stock or voting Common Stock of the Company.

      

      
        
          
          

        

        
          -6-

          
            

          

        

        
          
          

        

      

      5.8.    Corporate
        Records; Books.
        The
        corporate minute books of the Company and each of its predecessor companies,
        including BioCeutical Research, Inc. and AdvantaChem, Inc. (collectively,
        the
“Predecessor
        Companies”),
        have
        been made available to Buyer, are complete and correct in all material respects
        and contain all written minutes of the shareholders and board of directors
        (including any committees thereof) of the Company and the Predecessor
        Companies.

      

      5.9.    Financial
        Statements.
        The
        Company has previously provided Buyer with copies of the unaudited balance
        sheets, and the related statement of income of the Company for the fiscal
        year
        ended December 31, 2004 (the “Unaudited
        Year-End Financial Statements”)
        and
        the unaudited balance sheet and the unaudited statement of operations of
        the
        Company for the four-month period ended April 30, 2005 (the “Unaudited
        Interim Financial Statements”).
        Each
        of the Unaudited Year-End Financial Statements and the Unaudited Interim
        Financial Statements fairly present the financial position of the Company
        for
        and as of their respective periods. The Unaudited Year-End Financial Statements
        and the Interim Financial Statements are sometimes collectively referred
        to
        herein as the “Financial
        Statements.”
        The
        Financial Statements have not been prepared in accordance with generally
        accepted accounting principles (“GAAP”);
        however, the Company’s books and records are sufficient to permit the
        preparation of financial statements prepared in conformity with GAAP in
        compliance with the requirements of the Securities Exchange Commission
        (“SEC”)
        which
        may be incorporated into the financial statements of the Buyer for all periods
        from and after the Closing.

      

      5.10.    Undisclosed
        Liabilities; Material Defaults.
        Except
        as
        set forth in the Financial Statements or in Schedule
        5.10
        attached
        hereto, the Company does not have any outstanding material claims, liabilities
        or indebtedness, fixed or contingent. Except as set forth in Schedule
        5.10,
        the
        Company is not in default with respect to the material terms or conditions
        of
        any indebtedness.

      

      5.11.    Absence
        of Certain Changes.
        Except
        as set forth in Schedule
        5.11
        attached
        hereto or as contemplated by this Agreement, since April 30, 2005, the Company
        has not (a) made any declaration, setting aside or payment of any dividend
        or
        distribution (whether in payable in cash, stock or property) in respect of
        the
        Company’s capital stock or (b) made any redemption or other acquisition by the
        Company of the capital stock of the Company or any of the Subsidiaries, (c)
        suffered or incurred any damage, destruction or loss, whether or not covered
        by
        insurance having a material adverse effect on the Company’s properties and
        business, (d) made any increase in the rate of compensation or in the benefits
        payable or to become payable by the Company to its directors, officers,
        employees or consultants other than in the ordinary course of business and
        consistent with past practices, (e) entered into any contract, agreement,
        instrument or other obligation by the Company not in the ordinary course
        of
        business, including without limitation relating to any borrowing or capital
        expenditure, (f) disposed of any material asset other than in the ordinary
        course of business and consistent with past practice, (g) licensed or assigned
        any of its Intellectual Property (as defined in Section
        5.16(a)),
        other
        than in the ordinary course of business and consistent with past practices
        or
        (h) changed any accounting methods or principles.

      

      
        
          
          

        

        
          -7-

          
            

          

        

        
          
          

        

      

      5.12.    Title.

      

      (a)
        The
        Company has good and valid title to all of the property and assets reflected
        on
        the balance sheet included in the Interim Financial Statements or acquired
        after
        the date thereof, free and clear of all Liens, except for Liens which will
        be
        terminated at the Closing and Liens set forth in Schedule
        5.12
        attached
        hereto, and except for (i) statutory Liens not yet delinquent and (ii) as
        reflected in the balance sheets included in the Financial Statements or in
        the
        notes thereto.

      

      (b) Except
        as
        set forth in Schedule
        5.12,
        the
        Company does not own or lease any real property.

      

      5.13.    Litigation.
        There
        is
        no claim pending or, to the best knowledge of the Sellers, threatened, against
        any of the Sellers or the Company which, if adversely determined, would have
        a
        material adverse affect on the Company, its properties or business.

      

      5.14.    Taxes.
        The
        Company has filed all federal, state and local tax reports, returns, documents
        or statements relating to Taxes (as defined below), including any schedule
        or
        attachment thereto, and including any amendment thereof required to be filed
        as
        of the date hereof with any federal, state, local or other taxing authorities
        in
        respect of all relevant taxes, including without limitation, income, gross
        receipts, ad valorem, value added, sales, use, property, stamp, excise, use,
        withholding, payroll, employment and other tax of any kind whatsoever
        (collectively, “Taxes”).
        All
        Taxes required to be paid through the date of this Agreement have been paid
        and
        all Taxes for which liability has accrued are set forth in the Financial
        Statements or in Schedule
        5.14.

      

      5.15.    Compliance
        with Law and Applicable Governmental and Other
        Regulations.
        The
        Company is in material compliance with all applicable federal, state and
        local
        laws, rules, regulations and ordinances relating to its operations, property
        and
        business. There are no claims pending by any governmental authority, nor,
        to the
        best knowledge of the Sellers, are there any claims threatened, regarding
        any
        violations of any federal, state, or local laws, rules regulations or ordinances
        applicable to the Company, its operations, property or business.

      

      5.16.    Intellectual
        Property. 

      

      (a) The
        Company is the owner or licensee of all of the intellectual property rights
        (collectively, the “Intellectual
        Property Rights”)
        used
        by the Company in connection with its business, including, but not limited
        to,
        (i) software (source and executable or object code), algorithms, computer
        processing systems, techniques, methodologies, formulae, processes, compilations
        of information, drawings, proposals, job notes, reports, records and
        specifications and related documents in any media, including all modifications,
        enhancements, updates and derivatives, (ii) ideas, discoveries, inventions,
        design concepts, unique software and hardware configurations, and all materials
        developed therefrom, (iii) patents, patent applications, trademarks, trademark
        applications, trade names, logos, service marks, service mark applications,
        service names, internet domain names, access rights, web sites, electronic
        data
        links and copyrights and copyright applications, 

       

      
        
          
          

        

        
          -8-

          
            

          

        

        
          
          

        

      

      (iv)
        business plans, customer contacts, licenses, pricing strategy, competitive
        data,
        (v) any confidential information which is owned by a third party and provided
        under a license or confidentiality agreement, (vi) trade secrets which derive
        economic value, actual or potential, and any other confidential information
        which is determined by a court of competent jurisdiction not to rise to the
        level of trade secret under applicable law. Schedule
        5.16
        attached
        hereto sets forth all (x) registered patents, copyrights, trademarks, trade
        names and service marks owned or licensed by the Company, (y) applications
        for
        registrations of Intellectual Property filed by the Company and (z) all
        Intellectual Property Rights, URL, website addresses and other rights owned
        or
        used by the Company which are material to the Company and its business. The
        Company has complied in all material respects with all federal and international
        laws relating to Intellectual Property Rights and has made all necessary
        filings
        and has registered its material Intellectual Property Rights in all
        jurisdictions necessary to protect each of its Intellectual Property Rights
        set
        forth or required to be set forth in Schedule
        5.16.
        The
        consummation of the transactions consummated by this Agreement will not impair
        any material Intellectual Property Right.

      

      (b) The
        Company has the right to use each material Intellectual Property Right listed
        on
Schedule
        5.16
        without
        infringing the rights of any third-party. Except as set forth on Schedule
        5.16
        and
        which will terminate at the Closing Time, each of such Intellectual Property
        Rights is, and will continue to be at the Closing Time, free and clear of
        all
        royalty obligations and Liens. There are no claims pending, or, to the best
        knowledge of the Sellers, threatened, against the Company or any Seller that
        its
        use of the Intellectual Property Rights infringes the rights of any person.
        The
        Company and the Sellers have no knowledge of any third-party’s conflicting use
        of any such Intellectual Property Rights that conflicts with the Company’s
        Intellectual Property Rights.

      

      5.17.    Contracts.
        Set
        forth on Schedule
        5.17
        attached
        hereto is a list of each agreement, whether written or oral, to (i) perform
        contract manufacturing and/or distribution services, (ii) provide consulting
        services, (iii) sell any product or provide any service not included in clauses
        (i) or (ii), (iv) purchase or lease any real or personal property, (v) engage
        any party to provide any service or (vii) license any Intellectual Property
        (collectively, “Agreements”).
        All
        such Agreements are in full force and effect and no party is in breach of
        any
        such Agreement which would, with notice or the passage of time or both result
        in
        the termination of such Agreement or the payment of any damages or penalty
        pursuant to the terms of such Agreement.

      

      5.18.    Dealings
        with Affiliates.
        Except
        as
        set forth in Schedule
        5.18
        attached
        hereto, there are no oral or written agreements, arrangements or understandings
        to which the Company and any officer, director, or shareholder of the Company
        is
        a party. The Company is not obligated or liable to any officer, director
        or
        shareholder of the Company. 

      

      5.19.    Investment
        Representations.
        Each
        Seller represents and warrants to Buyer that (i) such Seller is acquiring
        the
        Hydron Shares for his own account and not with a view to distribution (as
        such
        term is used in Section 2(11) of the Common Stock Act), (ii) such Seller
        is an
        experienced and sophisticated investor and has such knowledge and experience
        in
        financial and business matters as are 

       

      
        
          
          

        

        
          -9-

          
            

          

        

        
          
          

        

      

      necessary
        to evaluate the merits and risks of the transactions contemplated by this
        Agreement, (iii) such Seller is an “accredited investor” as such term is defined
        in Rule 501(a) under the Securities Act of 1933, as amended (the “Securities
        Act”),
        and
        (iv) such Seller has been informed that neither the Company nor Buyer has
        registered the transactions contemplated by this Agreement under the Common
        Stock Act or any state, Common Stock or “blue sky” law. Each Seller acknowledges
        that it has been given a copy of the Buyer’s annual report on Form 10-K for the
        year ended December 31, 2004 and its quarterly report on Form 10-Q for the
        quarter ended March 31, 2005. Each Seller further acknowledges that it has
        been
        offered the opportunity to ask questions of, and receive answers from, Buyer;
        and the Sellers have been given full and complete access to all available
        information and data relating to the business and assets of the Company and
        obtained all information which the Sellers have deemed necessary in order
        to
        evaluate the opportunities, both financial and otherwise with respect to
        the
        Company.

      

      6.    COVENANTS

      

      6.1.    No
        Disposition; No Liens.
        Each
        Seller will not, between the date hereof and the Closing Time sell, dispose
        of,
        cause a Lien to be created against, or in any other manner encumber (other
        than
        pursuant to this Agreement), any of the Common Stock or enter into any agreement
        with any person or entity (other than Buyer) with respect to any of the
        foregoing matters. 

      

      6.2.    Regular
        Course of Business

      

      (a) Except
        as
        contemplated by this Agreement or with the prior written consent of Buyer,
        the
        Company shall operate its business in the ordinary and usual course, consistent
        with past management practices, shall maintain all of its properties in good
        order and condition, shall maintain all leases and contracts in effect without
        change and shall comply with all laws, rules and regulations applicable to
        its
        business.

      

      (b) Without
        limiting the generality of the foregoing, from the date of this Agreement
        through the Closing Time, without the prior written consent of Buyer, the
        Company shall not:

      

      
        	(i)  	
                hire
                  new management or key employees or terminate any existing employees
                  of the
                  Company; 

              

      

      
        	(ii)  	
                incur,
                  or become obligated for, any expense, capital commitment or other
                  cost
                  that is outside the ordinary course of business of the Company
                  or which
                  are in excess of $5,000; 

              

      

      
        	(iii)  	
                enter
                  into any agreement, including without limitation, any agreement
                  for
                  borrowed money, material to the Company or its business or which
                  would be
                  deemed a long-term liability under GAAP;

              

      

      
        	(iv)  	
                make
                  any changes to the compensation of any employee, including without
                  limitation, any bonus, increase or change in benefits, or grant
                  of any
                  option or right to acquire shares of capital stock of the Company
                  having a
                  fair value in excess of $10,000 in aggregate; or
                  

              

      

      
        	(v)  	
                issue
                  any shares of capital stock or rights to acquire shares of capital
                  stock
                  of the Company.

              

      

       

      
 

      
        
          
          

        

        
          -10-

          
            

          

        

        
          
          

        

      

      6.3.    Payments;
        No Solicitation.
        Each
        Seller acknowledges that any non-cash payments to it in respect of dividends
        or
        distributions on any of the Common Stock declared, set aside or paid are
        included as part of the Common Stock for purposes of this Agreement, and
        agrees
        to assign and deliver to Buyer at the Closing Time such payments. Between
        the
        date hereof and the Closing Time, neither Seller nor any affiliate or
        representative of such Seller shall solicit or encourage any person (other
        than
        Buyer) to acquire the Common Stock or sell or agree to sell or engage in
        a
        recapitalization, merger, sale of stock, sale of assets, other business
        combination or other similar transaction with or otherwise involving the
        Company
        or any of its subsidiaries or enter into any agreement with any person or
        entity
        (other than Buyer) with respect to any of the foregoing.

      

      6.4.    Certain
        Commitments.
        Each
        Seller hereby agrees that during the time this Agreement is in effect, at
        any
        meeting of the stockholders of the Company, however called, and in any action
        by
        consent of the stockholders of the Company, Seller shall vote the Common
        Stock:
        (i) in favor of any proposal for any recapitalization, merger, sale of stock,
        sale of assets, other business combination or other similar transaction between
        or involving the Company or any of its subsidiaries and Buyer or an affiliate
        of
        Buyer; (ii) after consultation with Buyer, against any proposal for
        any
        recapitalization, merger, sale of stock, sale of assets, other business
        combination or other similar transaction involving the Company or any of
        its
        Subsidiaries or which is reasonably likely to materially and adversely affect
        Buyer or prevent or delay the consummation of the transactions contemplated
        by
        this Agreement (other than a transaction referred to in clause (i) above);
        and
        (iii) subject to any required regulatory approvals, with respect to
        directors of the Company, in favor of any individuals designated by Buyer
        and,
        without prior written instructions from Buyer to the contrary, against any
        other
        individuals.

      

      6.5.    Filings;
        Consents; Other Actions.

      

      (a)
        Subject to the terms and conditions herein provided, (i)  each Seller
        and
        Buyer shall use all reasonable efforts to cooperate with one another in (A)
        determining which filings are required to be made prior to the Closing Time
        with, and which consents, approvals, permits or authorizations are required
        to
        be obtained prior to the Closing Time from, governmental or regulatory
        authorities of the United States, including without limitation, the SEC,
        and the
        States of Florida, Delaware and New York, in connection with the execution
        and
        delivery of this Agreement, the purchase and sale of the Shares, the issuance
        of
        the Hydron Shares and otherwise in connection with the consummation of the
        transactions contemplated hereby, and (B) timely making all such filings
        required on its part and timely seeking all such consents, approvals, permits
        or
        authorizations; and (iii) each Seller and Buyer shall use all reasonable
        efforts
        to take, or cause to be taken, all other action and do, or cause to be done,
        all
        other things necessary, proper or appropriate to consummate and make effective
        the transactions contemplated by this Agreement. If, at any time after the
        Closing Time, any further action on the part of Sellers is necessary or
        reasonably desirable to carry out the purpose of this Agreement, each Seller
        shall make reasonable efforts to take all such actions.

      

      
        
          
          

        

        
          -11-

          
            

          

        

        
          
          

        

      

      (b) Set
        forth
        on Schedule
        6.5
        attached
        hereto is a list of all consents, and notices of assignment (collectively,
        the
“Consents”)
        required in connection with the consummation of the transactions contemplated
        by
        this Agreement, the failure of which to obtain would result in a material
        adverse effect on the Company or its business, including, without limitation,
        all consents and notices of assignment relating to all material contracts
        and
        Intellectual Property Rights. The Company at its sole cost and expense shall
        obtain the Consents prior to the Closing Time.

      

      (c) Subject
        to the terms and conditions herein provided, each Seller shall use all
        reasonable efforts to cause the Company and its Subsidiaries to cooperate
        with
        the parties hereto with respect to the transactions contemplated by this
        Agreement. Without limiting the generality of the foregoing, each Seller
        shall
        use all reasonable efforts consistent with this Agreement to cause the Company
        and its Subsidiaries to cooperate with the parties hereto in connection with
        any
        filings, submissions, consents, approvals, permits, authorizations or other
        action referred to in Section
        6.5(a).

      

      (d) The
        parties hereto shall use all reasonable efforts consistent with this Agreement
        to cause each of the conditions precedent to the consummation of the
        transactions contemplated by this Agreement applicable to each of them,
        respectively, to be met as promptly as practicable.

      

      6.6.    Publicity.
        Subject
        to their respective legal obligations (including without limitation requirements
        under the federal securities laws and of stock exchanges and other similar
        regulatory bodies), the parties hereto shall consult with each other, and
        shall
        use reasonable efforts to agree upon the text of any press release, before
        issuing any such press release or otherwise making public statements (other
        than
        filings made pursuant to securities and other laws and regulations applicable
        to
        Buyer) with respect to the transactions contemplated hereby.

      

      7.    CONDITIONS

      

      7.1.    Conditions
        to Obligation of Sellers to Sell the Shares of Common
        Stock.
        The
        obligation of each Seller to sell the Shares of Common Stock owned by it
        shall
        be subject to the fulfillment or waiver by Sellers at or prior to the Closing
        Time of the following conditions:

      

      (a) Buyer
        shall have performed in all material respects its agreements contained in
        this
        Agreement required to be performed on or prior to the Closing Time and the
        representations and warranties of Buyer contained in this Agreement shall
        be
        true and correct in all material respects as of the date when made and (unless
        made as of a specified date) as of the Closing Time, and Sellers shall have
        received a certificate of Buyer, dated the date of the Closing Time, certifying
        to such effect.

      

      
        
          
          

        

        
          -12-

          
            

          

        

        
          
          

        

      

      (b) Neither
        the Company or any Seller nor Buyer shall be subject to any order or injunction
        of a court of competent jurisdiction which prohibits the consummation of
        the
        transactions contemplated by this Agreement. If any such order or injunction
        shall have been issued against the Company or any Seller, each Seller agrees
        to
        use its reasonable best efforts to have any such injunction lifted.

      

      (c) All
        material consents, authorizations, orders and approvals of (or filings or
        registrations with) any governmental commission, board or other regulatory
        body
        (including, without limitation, the SEC and the various states in connection
        with the merger of the Predecessor Companies with and into the Company) required
        in connection with the execution, delivery and performance of this Agreement
        shall have been obtained or made.

      

      (d) There
        shall be no action, suit or proceeding pending against any of the parties
        hereto
        which would or would reasonably be expected to prevent or materially delay
        transactions contemplated by this Agreement or result in material damages
        in
        connection herewith.

      

      (e) Buyer
        shall have executed and delivered this Agreement, and shall have delivered
        at
        the Closing Time to the Seller stock certificates representing all of the
        Hydron
        Shares, executed by the appropriate officers of the Company, or shall deliver
        a
        copy of its instruction letter to its stock transfer agent to issue and deliver
        the Hydron Shares required to be issued and delivered to each Seller at the
        Closing Time.

      

      (f) Pollack
        and Reitz shall have executed the employment agreements, in the forms attached
        as Exhibits
        B-1 and B-2
        hereto
        (collectively, the “Employment
        Agreements”)

      

      (g) Buyer
        shall have delivered such other documents and instruments required hereunder
        or
        reasonably requested by the Sellers.

      

      7.2.    Conditions
        to Obligation of Buyer to Purchase the Shares of Common
        Stock.
        The
        obligations of Buyer to purchase the Shares of Common Stock shall be subject
        to
        the fulfillment or waiver by Buyer at or prior to the Closing Time of the
        following conditions:

      

      (a) Each
        of
        the Sellers shall have performed in all material respects its agreements
        contained in this Agreement required to be performed on or prior to the Closing
        Time and the representations and warranties of such Seller contained in this
        Agreement shall be true and correct in all material respects as of the date
        when
        made and (unless made as of a specified date) as of the Closing Time, and
        Buyer
        shall have received a certificate of such Seller, dated the date of the Closing
        Time, certifying to such effect.

      

      (b) Neither
        Buyer nor the Company or any Seller shall be subject to any order or injunction
        of a court of competent jurisdiction which prohibits the consummation of
        the
        transactions contemplated by this Agreement. If any such order or injunction
        shall have been issued against Buyer, Buyer agrees to use its reasonable
        best
        efforts to have any such injunction lifted.

      

      
        
          
          

        

        
          -13-

          
            

          

        

        
          
          

        

      

      (c) All
        material consents, authorizations, orders and approvals of (or filings or
        registrations with) any governmental commission, board or other regulatory
        body
        (including, without limitation, the SEC and the various states in connection
        with the merger of the Predecessor Companies with and into the Company) or
        any
        other third party required in connection with the execution, delivery and
        performance of this Agreement shall have been obtained or made.

      

      (d) There
        shall be no action, suit or proceeding pending or threatened against any
        of the
        parties hereto which would or would reasonably be expected to prevent or
        materially delay the transactions contemplated by this Agreement or result
        in
        material damages in connection herewith.

      

      (e) On
        or
        before the Closing Time, each of the Predecessor Companies shall have been
        merged with and into the Company in one or more transactions in which the
        Company shall be the surviving corporation (the “Mergers”)
        and
        the Company shall deliver to the Buyer copies of the articles of merger and
        the
        certificate of merger certified by the Secretary of State of the State of
        Florida and the Secretary of State of the State of Delaware, respectively,
        evidencing such Mergers

      

      (f) The
        Sellers shall have executed and delivered this Agreement, and shall have
        delivered at the Closing to the Buyer stock certificates representing all
        of the
        Company Shares, duly endorsed for transfer to the Buyer or together with
        stock
        powers duly executed in blank.

      

      (g) Buyer
        shall have executed the Employment Agreements between Buyer and each of Pollack
        and Reitz.

      

      (h) Buyer
        shall have delivered such other documents and instruments required hereunder
        or
        reasonably requested by the Sellers.

      

      8.    INDEMNIFICATION

      

      8.1.    Survival
        of Representations and Warranties.
        The
        representations and warranties made in this Agreement shall not terminate
        at the
        Closing Time and shall survive until the second anniversary of the Closing
        Time.

      

      8.2.    Indemnification
        by the Sellers.
        Each of
        the Buyer and its officers, directors, employees, shareholders, representatives
        and agents shall be indemnified and held harmless by the Sellers, jointly
        and
        severally, at all times after the date of this Agreement, against and in
        respect
        of any and all damage, loss, deficiency, liability, obligation, commitment,
        cost
        or expense (including the reasonable fees and expenses of counsel) resulting
        from, or in respect of, any of the following:

      

      
        
          
          

        

        
          -14-

          
            

          

        

        
          
          

        

      

      (a) any
        misrepresentation, breach of warranty, or non-fulfillment of any obligation
        on
        the part of any Seller or the Company under this Agreement, or contained
        in any
        Schedule or Exhibit to this Agreement or from any material misrepresentation
        in
        or omission from any certificate, schedule, other agreement or instrument
        executed by any Seller or the Company and delivered hereunder; and

      

      (b) any
        Taxes
        owed by the Company, the Predecessor Companies or the Sellers with respect
        to
        any Tax year or portion thereof ending on or before the Closing
        Time.

      

      8.3.    Indemnification
        by Buyer.
        Each
        Seller shall be indemnified and held harmless by the Buyer at all times after
        the date of this Agreement, against and in respect of any and all damage,
        loss,
        deficiency, liability, obligation, commitment, cost or expense (including
        the
        reasonable fees and expenses of legal counsel) resulting from, or in respect
        of,
        any of the following:

      

      (a) any
        misrepresentation, breach of warranty, or non-fulfillment of any obligation
        on
        the part of Buyer under this Agreement, or contained in any Schedule or Exhibit
        to this Agreement or from any material misrepresentation in or omission from
        any
        certificate, schedule, other agreement or instrument executed by buyer and
        delivered hereunder; and

      

      (b) any
        Taxes
        owed by the Company or the Sellers with respect to any Tax year or portion
        thereof beginning after the Closing Time.

      

      8.4.    Third-Party
        Claims.
        The
        following procedures shall be applicable with respect to indemnification
        for
        third-party Claims (as defined below):

      

      (a) Promptly
        after receipt by the party seeking indemnification hereunder (hereinafter
        referred to as the “indemnitee”)
        of
        notice of the commencement of any (a) Tax audit or proceeding for the assessment
        of Tax by any taxing authority or any other proceeding likely to result in
        the
        imposition of Tax liability or obligation or (b) any action or the assertion
        of
        any Claim, liability or obligation by a third party (whether by legal process
        or
        otherwise), against which assessment, imposition, Claim, liability, or
        obligation any other party to this Agreement (hereinafter the “indemnitor”)
        is, or
        may be, required under this Agreement to indemnify such indemnitee, the
        indemnitee will, if a Claim thereon is to be, or may be, made against the
        indemnitor, notify the indemnitor in writing of the commencement or assertion
        thereof and give the indemnitor a copy of such Claim, process and all legal
        pleadings. 

      

      (b) The
        indemnitor shall have the right to participate in the defense of such action
        with counsel of reputable standing. The indemnitor shall have the right to
        assume and control the defense of such action unless such action, if adversely
        determined, might (1) result in injunctions or other equitable remedies in
        respect of the indemnitee or its business; (2) result in liabilities which,
        taken with other then existing claims, would not be fully indemnified hereunder;
        or (3) have an adverse impact on the business or financial condition of the
        indemnitee after the Closing Time. The indemnitor and the indemnitee shall
        cooperate in the defense of such Claims. 

      

      
        
          
          

        

        
          -15-

          
            

          

        

        
          
          

        

      

      (c) In
        the
        case that the indemnitor shall assume or participate in the defense of such
        audit, assessment or other proceeding as provided herein, the indemnitee
        shall
        make available to the indemnitor all relevant records and take such other
        action
        and sign such documents as are necessary to defend such audit, assessment
        or
        other proceeding in a timely manner. If the indemnitee shall be required
        by
        judgment or settlement agreement to pay any amount in respect of any obligation
        or liability against which the indemnitor has agreed to indemnify the indemnitee
        under this Agreement, the indemnitor shall promptly reimburse the indemnitee
        in
        an amount equal to the amount of such payment plus all reasonable expenses
        (including reasonable fees and expenses of legal counsel) incurred by such
        indemnitee in connection with such obligation or liability.

      

      (d) Prior
        to
        paying or settling any Claim, the indemnitee must first supply the indemnitor
        with a copy of a final court judgment or decree holding the indemniteee liable
        on such Claim, or in the case of a settlement of such Claim, the indemnitee
        must
        first receive the written approval of the terms and conditions of such
        settlement from the indemnitor, which approval may not be unreasonably be
        withheld.

      

      (e) An
        indemnitee shall have the right to employ its own legal counsel and participate
        in any case, but the fees and expenses of such legal counsel shall be at
        the
        expense of the indemnitee unless (a) the employment of such legal counsel
        shall
        have been approved in advance by the indemnitor in connection with the defense
        of the Claim, or (b) such indemnitee shall have reasonably concluded that
        there
        may be defenses available to it that would be contrary to, or inconsistent
        with,
        those available to the indemnitor. In any such case, the indemnitee shall
        be
        entitled to reimbursement for the fees and expenses of one such legal
        counsel.

      

      (f) For
        purposes of this Section, a “Claim” means any action, claim, obligation,
        liability, expense, lawsuit, demand, suit, inquiry, hearing, investigation,
        notice of a violation, litigation, proceeding, arbitration, or other dispute,
        whether civil, criminal, administrative
        or otherwise.

      

      9.    NONCOMPETE

      

      9.1    Non-Competition
        Covenant.

      

      (a)  As
        a
        material and valuable inducement for the Buyer to enter into this Agreement,
        pay
        and issue the shares of Hydron Stock hereunder to Sellers and consummate
        the
        transactions provided for herein, during the “Restricted
        Period”
        (as
        hereinafter defined), each Seller agrees, unless otherwise permitted by Buyer
        in
        writing, that he shall not, directly or indirectly, for himself or on behalf
        of
        or in conjunction with any other person, persons, company, partnership,
        corporation or business of whatever nature:

      

      
        
          
          

        

        
          -16-

          
            

          

        

        
          
          

        

      

      (i)  engage,
        as an officer, director, shareholder, owner, partner, joint venturer or in
        a
        managerial capacity, whether as an employee, independent contractor, consultant
        or advisor or as a sales representative, in any business of the same nature
        or
        similar to the business of Buyer, whether conducted by the Company or in
        direct
        competition with Buyer or the Company or any subsidiary or affiliate of Buyer
        (collectively with Buyer, the “Hydron
        Entities”
        and
        each (including Buyer), a “Hydron
        Entity”),
        within the United States (the “Restricted
        Territory”);

      

      (ii)  solicit
        any person who is, at that time, or who has been within one (1) year prior
        to
        that time, an employee of any Hydron Entity for the purpose or with the intent
        of enticing such employee away form or out of the employ of any Hydron Entity;
        or

      

      (iii)  solicit
        any person or entity which is, at that time, or which has been within one
        (1)
        year prior to that time, a customer or supplier of any Hydron Entity for
        the
        purpose of soliciting or selling products or services in competition with
        any
        Hydron Entity within the Restricted Territory.

      

      (b)  Notwithstanding
        the above, the foregoing covenant shall not be deemed to prohibit any Seller
        from acquiring as an investment not more than two percent (2%) of the capital
        stock of a competing business, whose stock is traded on a national securities
        exchange or over-the-counter. 

      (c)  As
        used
        in this Agreement, the term “Restricted
        Period”
        shall
        mean and include with respect to each Seller, (A) in the case of the
        prohibitions set forth in Section 9.1(a)(i) and (ii), any time while such
        Seller
        is employed by any Hydron Entity and (B), in the case of the prohibition
        set
        forth in Section 9.1(a)(iii), the longer of (x) a period of three (3) years,
        from the Closing Time to the third (3rd) anniversary of the Closing Time
        or (y)
        with respect to each Seller employed by a Hydron Entity for a period of two
        (2)
        years following the effective date of the termination of such Seller’s
        employment with any Hydron Entity (regardless of the cause, reason or
        justification of such termination.

      

      (d)  In
        recognition of the substantial nature of such potential damages and the
        difficulty of measuring economic losses to Buyer as a result of a breach
        of the
        foregoing covenants, and because of the immediate and irreparable damage
        that
        could be cause to Buyer for which it would have no other adequate remedy,
        each
        Seller agrees that in the event of breach by such Seller of the foregoing
        covenant, Buyer and each Hydron Entity shall be entitled to specific performance
        of this provision and injunctive and other equitable relief. 

      

      (e)  It
        is
        agreed by the parties that the foregoing covenants in this Section
        9.1
        impose a
        reasonable restraint on the Sellers in light of the activities and business
        of
        the Company and the Hydron Entities on the date of the execution of this
        Agreement and the current plans of the Hydron Entities; but it is also the
        intent of Buyer and the Sellers that such covenants be construed and enforced
        in
        accordance with the changing activities, business and locations of the Hydron
        Entities, whether before or after the date of termination of the employment
        of
        such Seller provided, that the applicable Seller participated in the development
        of the changed activity, business or location. For example, if, during the
        Restricted Period, a Hydron Entity engages in new and different activities,
        enters a new business or establishes new locations for its current activities
        or
        business in addition to or its existing activities or business or the locations
        currently established therefore, then such Seller will be precluded from
        soliciting the customers or employees of such new activities or business
        or from
        such new location and from directly competing with such new business within
        the
        Restricted Territory or within 100 miles of its then-established operating
        location(s) through the Restricted Period if the Seller was involved in the
        development of such new businesses, locations or activities.

      

      
        
          
          

        

        
          -17-

          
            

          

        

        
          
          

        

      

      (f)  The
        covenants in this Section
        9.1
        are
        severable and separate, and the unenforceability of any specific covenant
        shall
        not affect the provisions of any other covenant. Moreover, in the event any
        court of competent jurisdiction shall determine that the scope, time or
        territorial restrictions be enforced to the fullest extent which the court
        deems
        reasonable, and the Agreement shall be reformed in accordance
        therewith.

      

      (g)  All
        the
        covenants in this Section
        9.1
        shall be
        construed as an agreement independent of any other provision in this Agreement,
        and the existence of any claim or cause of action of any Seller against Buyer,
        whether predicated on this Agreement or otherwise, shall not constitute a
        defense to the enforcement by Buyer of such covenants. Further, this
Section
        9.1
        shall
        survive the Closing and the termination of such Seller’s employment with a
        Hydron Entity. It is specifically agreed that the Restricted Period, during
        which the agreements and covenants of the Seller made in this Section
        9.1
        shall be
        effective, shall be computed by excluding from such computation any time
        during
        which such Seller is in violation of any provision of this Section
        9.1.

      

      9.2    Non-Disclosure;
        Confidentiality.

      

      (a)  Confidential
        Information.
        By
        virtue of the Sellers’ respective prior or future employment, association or
        involvement with the Company of other Hydron Entity, such Seller may have
        obtained or may hereafter obtain confidential or proprietary information
        developed, or to be developed, by the Company of other Hydron Entity.
“Confidential Information” means all proprietary or confidential business
        information, whether in oral, written, graphic, machine-readable or tangible
        form, and whether or not registered, and including all notes, plans, records,
        documents and other evidence thereof, including but not limited to all: patents,
        patent applications, copyrights, trademarks, trade names, service marks,
        service
        names, “know how,” customer lists, details of client or consulting contracts,
        pricing policies, operational methods, marketing plans or strategies, product
        development techniques or plans, procurement and sales activities, promotion
        and
        pricing techniques, credit and financial data concerning customers, business
        acquisition plans or any portion or phase of any scientific or technical
        information, discoveries, computer software or programs used or developed
        in
        whole or in part by any Hydron Entity (including source or object codes),
        processes, procedures, formulas or improvements of any Hydron Entity;
        algorithms; computer processing systems and techniques; price lists, customer
        lists; procedures; improvements, concepts and ideas; business plans and
        proposals; technical plans and proposals; research and development; budgets
        and
        projections; technical memoranda, research reports, designs and specifications;
        new product and service developments; comparative analyses of competitive
        products, services and operating procedures; and other information, data
        and
        documents now existing or later acquired by an Hydron Entity, regardless
        of
        whether any of such information, data or documents qualify as a “trade secret”
        under applicable Federal or State law. “Confidential Information” shall not
        include (a) any information which is in the public domain during the period
        of
        service by the Sellers or becomes public thereafter, provided such information
        is not in the public domain as a consequence of disclosure by any Seller
        in
        violation of this Agreement, and (b) any information not considered confidential
        information by similar enterprises operating in the retail health and beauty
        aide industry or otherwise in the ordinary course.

      

      
        
          
          

        

        
          -18-

          
            

          

        

        
          
          

        

      

      (b)  Non-Disclosure.
        Each
        Seller agrees that, except as directed by such Seller’s Hydron Entity employer
        (if any), as required or otherwise contemplated under this Agreement or such
        Seller’s Employment Agreement (if any) or as otherwise required by law, he will
        not at any time (including during the term of such Seller’s employment by a
        Hydron Entity (if any) or at any time thereafter), except as may be expressly
        authorized by the Hydron Entity in writing, disclose to any person or use
        any
        Confidential Information whatsoever for any purpose whatsoever, or permit
        any
        person whatsoever to examine and/or make copies of any reports or any documents
        or software (whether in written form or stored on magnetic, optical or other
        mass storage media) prepared by him or that come into his possession or under
        his control by reason of his employment by an Hydron Entity or by reason
        of any
        consulting or software development services he has performed or may in the
        future perform for an Hydron Entity which contain or are derived from
        Confidential Information. Each Seller further agrees that while employed
        and an
        Hydron Entity, no Confidential Information shall be removed from the Hydron
        Entity’s business premises, without the prior written consent of such Hydron
        Entity. In addition, each of the Sellers hereby acknowledge that he is aware
        of
        the restrictions imposed by federal securities laws on persons possessing
        material non-public information with respect to SEC reporting companies and
        agree that neither Seller will effect any transactions in the stock of Buyer
        without compliance with such laws.

      

      (c)  Hydron
        Group Property.
        As used
        in this Agreement, the term “Hydron
        Group Property”
        means
        all documents, papers, computer printouts and disks, records, customer or
        customer lists, files, manuals, supplies, computer hardware and software,
        equipment, inventory and other materials that have been created, used or
        obtained by any Hydron Entity, or otherwise belonging to any Hydron Entity,
        as
        well as any other materials containing Confidential Information as defined
        above. Each Seller recognizes and agrees that:

      

      (i)  All
        the
        Hydron Group Property shall be and remain the property of the Hydron Entity
        to
        which such belongs;

      

      (ii)  The
        Sellers will preserve, use and hold the Hydron Group Property only for the
        benefit of Buyer and its affiliates and to carry out the business of the
        Hydron
        Entity, Buyer and its affiliates; and

      

      (iii)  When
        any
        Seller’s employment is terminated, such Seller will immediately deliver and
        surrender to the Hydron Entity all the Hydron Group Property, including all
        copies, extracts or any other types of reproductions, which such Seller has
        in
        his possession or control.

      

      
        
          
          

        

        
          -19-

          
            

          

        

        
          
          

        

      

      10.    TERMINATION

      

      10.1    Methods
        of Termination.
        This
        Agreement may be terminated and the transactions herein contemplated may
        be
        abandoned at any time:

      

      (a) by
        mutual
        consent of the Buyer, the Sellers and the Company;

      

      (b) by
        the
        Buyer or the Sellers and the Company, collectively, if the transactions
        contemplated by the Agreement have not been consummated on or before [July
        31,
        2005]; provided,
        however,
        that if
        the failure to consummate the transactions contemplated by this Agreement
        as of
        that date has resulted from the breach or default of any party with respect
        to
        its respective obligations under this Agreement on or before such date, such
        party may not terminate this Agreement pursuant to this Section
        10.1(b),
        and
        each other party to this Agreement shall at its option enforce its rights
        against such breaching or defaulting party and seek any remedies against
        such
        party, in either case as provided hereunder and by applicable law;
        or

      

      (c) by
        notice
        given by each of the Sellers and the Company or the Buyer if as of the Closing
        Time (including any extensions) any of the conditions specified in Sections
        7.1
        or 7.2 of this Agreement, respectively, shall not have been satisfied or
        if the
        Buyer or either Seller or the Company, respectively, is otherwise in default
        under this Agreement.

      

      10.2    Procedure
        Upon Termination.
        In
        the
        event of termination and abandonment pursuant to Section
        10.1
        hereof,
        and subject to the proviso contained in Section
        10.1(b),
        this
        Agreement shall terminate and be abandoned, without further action by any
        of the
        parties hereto. If this Agreement is terminated as provided herein:

      

      (a) each
        party shall redeliver all documents and other material of any party relating
        to
        the transactions contemplated hereby, whether obtained before or after the
        execution hereof, to the party furnishing the same;

      

      (b) all
        information received by any party hereto with respect to the business of
        the
        other party or the Company (other than information which is a matter of public
        knowledge or which has heretofore been or is hereafter published in any
        publication for public distribution or filed as public information with any
        governmental authority) shall not at any time be used for the advantage of,
        or
        disclosed to third parties by, such party to the detriment of the party
        furnishing such information; and 

      

      (c) no
        party
        hereto shall have any further liability or obligation to any other party
        under
        or in connection with this Agreement; provided,
        however,
        that
        the non-breaching or non-defaulting party shall not be foreclosed from bringing
        a Claim or cause of action or otherwise recovering from the breaching or
        defaulting party for such breach or default.

      

      
        
          
          

        

        
          -20-

          
            

          

        

        
          
          

        

      

      11.    GENERAL
        PROVISIONS

      

      11.1.    Notices.
        Any
        notice required to be given hereunder shall be sufficient if in writing,
        and
        sent by facsimile transmission and by courier service (with proof of service),
        hand delivery (with proof of delivery) or certified or registered mail (return
        receipt requested and first-class postage prepaid), addressed as
        follows:

      

      If
        to
        Buyer:

       

      Hydron
        Technologies, Inc.

      2201
        W.
        Sample Road

      Building
        9, Suite 7-B

      Pompano
        Beach, FL 33073-3006

      Att:
        Chief Operating Officer

      Facsimile:
        (954) 861-6400

      Telephone:
        (954) 861-6401

      

      With
        a
        copy to:

      

      Ruden
        McClosky Smith Schuster &

      Russell,
        P.A.

      200
        East
        Broward Boulevard, Suite 1700

      Fort
        Lauderdale, FL 33301

      Attn:
        Robert C. Brighton, Jr., Esq. 

      Facsimile:
        (954) 333-4073 

      Telephone:
        (954) 527-2473 

      

      If
        to
        the Company or the Sellers:

      

      Clinical
        Results, Inc.

      4400
        34th
        Street
        North

      Warehouse
        F

      St.
        Petersburg, FL 33714

      Facsimile:
        (727) 344-0519 

      Telephone:
        (727) 344-3920

      Att:
        President

      

      With
        a
        copy to:

      

      Att:
          

      Facsimile:
        

      Telephone:
        

      

      or
        to
        such other address as any party shall specify by written notice so given,
        and
        such notice shall be deemed to have been delivered as of the date so
        telecommunicated, personally delivered or mailed.

      

      
        
          
          

        

        
          -21-

          
            

          

        

        
          
          

        

      

      11.2.    Assignment;
        Binding Effect.
        Neither
        this Agreement nor any of the rights, interests or obligations hereunder
        shall
        be assigned by any of the parties hereto (whether by operation of law or
        otherwise) without the prior written consent of the other parties. Subject
        to
        the preceding sentence, this Agreement shall be binding upon and shall inure
        to
        the benefit of the parties hereto and their respective successors and assigns.
        Until the Closing Time or termination of this Agreement pursuant to Section
        10.1,
        or
10.2,
        the
        Common Stock (and any transfer thereof) shall be subject to this
        Agreement.

      

      11.3.    Entire
        Agreement
        This
        Agreement constitutes the entire agreement among the parties with respect
        to the
        subject matter hereof and supersedes all prior agreements and understandings
        (oral and written) among the parties with respect thereto. No addition to
        or
        modification of any provision of this Agreement shall be binding upon any
        party
        hereto unless made in writing and signed by all parties hereto.

      

      11.4.    Amendment.
        This
        Agreement may be amended by the parties hereto by an instrument in writing
        signed by or on behalf of each of the parties hereto.

      

      11.5.    GOVERNING
        LAW.
        THIS
        AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS
        OF THE
        STATE OF FLORIDA WITHOUT REGARD TO ITS RULES OF CONFLICT OF LAWS.

      

      11.6.    Counterparts.
        This
        Agreement may be executed by the parties hereto (including by facsimile
        transmission) with separate counterpart signature pages or in separate
        counterparts, each of which when so executed and delivered shall be an original,
        but all such counterparts shall together constitute one and the same
        instrument.

      

      11.7.    Headings. Headings
        of the Sections of this Agreement are for the convenience of the parties
        only,
        and shall be given no substantive or interpretive effect
        whatsoever.

      

      11.8.    Interpretation.
        In this
        Agreement, unless the context otherwise requires, words describing the singular
        number shall include the plural and vice versa, and words denoting any gender
        shall include all genders and words denoting natural persons shall include
        corporations and partnerships and vice versa.

      

      11.9.    Waivers. Except
        as
        provided in this Agreement, no action taken pursuant to this Agreement,
        including without limitation any investigation by or on behalf of any party,
        shall be deemed to constitute a waiver by the party taking such action of
        compliance with any representations, warranties, covenants or agreements
        contained in this Agreement. The waiver by any party hereto of a breach of
        any
        provision hereunder shall not operate or be construed as a waiver of any
        prior
        or subsequent breach of the same or any other provision hereunder.

      

      
        
          
          

        

        
          -22-

          
            

          

        

        
          
          

        

      

      11.10.    Severability.
        Any term
        or provision of this Agreement which is invalid or unenforceable in any
        jurisdiction shall, as to that jurisdiction, be ineffective to the extent
        of
        such invalidity or unenforceability without rendering invalid or unenforceable
        the remaining terms and provisions of this Agreement or otherwise affecting
        the
        validity or enforceability of any of the terms or provisions of this Agreement
        in any other jurisdiction. If any provision of this Agreement is so broad
        as to
        be unenforceable, the provision shall be interpreted to be only so broad
        as is
        enforceable.

      

      11.12.    Enforcement
        of Agreement.
        The
        parties hereto agree that irreparable damage would occur if any of the
        provisions of this Agreement were not performed in accordance with its specific
        terms or was otherwise breached. It is accordingly agreed that the parties
        shall
        be entitled to an injunction or injunctions to prevent breaches of this
        Agreement and to enforce specifically the terms and provisions hereof, this
        being in addition to any other remedy to which they may be entitled at law
        or in
        equity.

      

      11.13.    Costs.
        Each
        of
        the Sellers and Buyer shall bear its own respective costs, and the Sellers
        shall
        bear the costs of the Company. 

      

      11.14.    Schedules.
        Information
        or disclosure provided on any Schedule shall constitute disclosure for purposes
        of all Schedules to which such information or disclosure would be
        responsive.

      

      11.15.    No
        Third Party Beneficiaries.
        Nothing
        in this Agreement shall be interpreted to provide to grant, expand, increase,
        broaden or enlarge any rights or remedies which third parties would have
        against
        the Company or any of the Sellers had the parties not entered into this
        Agreement and the transactions contemplated hereby not taken place.

      

      11.16.    Due
        Diligence.
        Prior
        to
        the Closing Time, Sellers and the Company shall provide Buyer with access
        to
        such information as Buyer may reasonably request regarding the business of
        the
        Company and the Predecessor Companies, including without limitation, all
        financial information, Contracts and corporate documentation relating to
        the
        Company or the Predecessor Companies.

      

      11.17.    Lock-up
        Agreements.
        Each
        Seller agrees, if requested by Buyer and an underwriter of common stock (or
        other securities) of Buyer, not to sell or otherwise transfer or dispose
        of any
        common stock (or other securities) of Buyer held by such Seller during the
        90
        day period following any registration statement filed by Buyer under the
        Securities Act, provided that all executive officers, directors, and chief
        executives or presidents of subsidiaries, of Buyer enter into similar
        agreements. If requested by the underwriters, the Sellers shall execute a
        separate agreement to the foregoing effect. Buyer may impose stop-transfer
        instructions with respect to the shares (or securities) subject to the foregoing
        restriction until the end of such period.

       

      
        11.18    Board
          of Directors.
          Buyer
          agrees to appoint and nominate Pollock and one other designee of Sellers
          to the
          Board of Directors of the Buyer, and to nominate and use its best efforts
          to
          cause the election of such nominees or other nominees of Sellers as directors
          at
          the next annual meeting of the shareholders of the Buyer.

        

        

        [REMAINDER
          OF PAGE INTENTIONALLY LEFT BLANK]

         

      

      

      
        
          
          

        

        
          -23-

          
            

          

        

        
          
          

        

      

      IN
        WITNESS WHEREOF,
        the
        parties have executed this Agreement and caused the same to be duly delivered
        on
        their behalf as of the day and year first written above.

      

      BUYER:

       

      HYDRON
        TECHNOLOGIES, INC.

       

      By:
         /s/
        Banakus

      
        
          

        

      

      Name:
        Richard Banakus

      Title:
        Interim President

       

      THE
        COMPANY:

       

      CLINICAL
        RESULTS, INC.

       

      By:  
        /s/ Pollock

      
        
          

        

      

      Name:
        David Pollock

      Title:
        President

       

      SELLERS:

       

      /s/
        Pollock

      
        
          

        

      

      DAVID
        POLLOCK, individually

       

       

      /s/
        Reitz

      
        
          

        

      

      R.
        DOUGLAS REITZ, individually

      

      

      
        
          
          

        

        
          -24-

          
            

          

        

        
          
          

          
             

          

        

      

      EXHIBIT
        A

       

      RESTRICTIVE
        LEGEND

       

      “THE
        SHARES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT
        OF
        1933, AS AMENDED, AND MAY NOT BE SOLD, PLEDGED, OR OTHERWISE TRANSFERRED
        WITHOUT
        AN EFFECTIVE REGISTRATION THEREOF UNDER SUCH ACT OR AN OPINION OF COUNSEL,
        SATISFACTORY TO THE COMPANY AND ITS COUNSEL, THAT SUCH REGISTRATION IS NOT
        REQUIRED.”

       

      

      
        
          
          

        

          A-1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00087-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00087-of-00352.parquet"}]]